In addition to covering emerging developments in vaccine science, design and technology, the Vaccinology During and After COVID-19 Keystone Symposium held in Atlanta on September 17-20, 2023, highlighted many aspects of health equity surrounding development and deployment of vaccines globally. Dr. Barney Graham, of Morehouse School of Medicine, set the stage for these conversations with his Keynote Address, which covered the current state of the field, future directions, and challenges in global vaccine equity that need to be solved in the context of pandemic preparedness and response.
This message is of critical importance to the global research community, and public health worldwide, so we are releasing this presentation open access to inform broader audiences about these issues and inspire them to take action. View the presentation below, which includes Welcome Address by meeting organizer Dr. Bali Pulendran outlining the vision and goals of the conference, followed by Dr. Graham's Keynote Address and audience Q&A on how to solve these health equity issues.
Plenary Talk by Dr. Gagandeep Kang(Bill and Melinda Gates Foundation) Enhancing Vaccine Equity Before and After COVID-19
Workshop:Equity in Vaccine Responses This workshop highlights biological differences in vaccine responses across different demographics of the population that should be considered when designing vaccines and developing dosing to ensure safety and efficacy across diverse populations. Speakers will represent diverse global perspectives:
Fan Zhou (University of Bergen, Norway) Age Related Differences in Kinetics and Magnitude of SARS-CoV-2 and Endemic Human Coronavirus Reactive Antibody Responses After Vaccination and Infection
Lobke Hensen (University Medical Center Utrecht, Netherlands) T cell Immune Response Induced by Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Down Syndrome
Francesco Berlanda-Scorza† (GSK, Italy) A Strategic Model and Industry Collaboration for Sustainable Development of Vaccines against Neglected Diseases
Jerome Nyhalah Dinga (University of Buea, Cameroon) Combating the Loss in Childhood Immunization Gains in Rural Communities and Vaccination of Disabled Persons due to Covid-19: The Approach of Building Relationships and Harnessing Power in the Community
Ramya Madhavan (Christian Medical College, India) Characterization of Immune Responses to Two and Three Doses of the Adenoviral Vectored Vaccine ChAdOx1 nCov-19 and the Whole Virion Inactivated Vaccine BBV152 in a Mix-and-match Study in India
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.